# Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496

> **NCT00898963** · — · COMPLETED · sponsor: **ECOG-ACRIN Cancer Research Group** · enrollment: 175 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **GENETIC:** gene expression analysis
- **GENETIC:** microarray analysis
- **GENETIC:** polymorphism analysis
- **OTHER:** diagnostic laboratory biomarker analysis
- **OTHER:** immunohistochemistry staining method
- **OTHER:** immunologic technique

## Key facts

- **NCT ID:** NCT00898963
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04-18
- **Primary completion:** 2011-02-11
- **Final completion:** 2011-02-11
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2020-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00898963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00898963, "Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00898963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*